RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PARLAGRECO E
Collezione AOU San Luigi di Orbassano

Items : 13

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Novello S; Gianetta M; Di Maio M; D'Amiano C; Capelletto E; Bianco V; Bertaglia V; Napoli VM; Leone G; Cecchi C; Audisio A; Turco F; Delcuratolo MD; Cetoretta V; Pisano C; Parlagreco E; Garbo E; Ferrari G; Del Rio B; Cani M; Persano I; Scagliotti GV; Bironzo P;

Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review. in Journal of clinical medicine / J Clin Med. 2023 Jan 16;12(2):717. doi: 10.3390/jcm12020717.

2023
AOU San Luigi di Orbassano

Zappi A; Persano I; Galvani L; Parlagreco E; Andrini E; Campana D; Brizzi MP; Lamberti G; La Salvia A;

Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives. in Journal of clinical medicine / J Clin Med. 2023 Dec 15;12(24):7715. doi: 10.3390/jcm12247715.

2023
AOU San Luigi di Orbassano

Persano I; Formelli MG; Stumpo S; Parlagreco E; Lauricella E; Rodriquenz MG; Guerrera LP; Zurlo IV; Campana D; Brizzi MP; Cives M; La Salvia A; Lamberti G;

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Parlagreco E; Ungaro A; Audisio M; Audisio A; Samuelly A; Pisano C; Urban S; Tucci M; Angusti T; Parente A; Di Stefano RF; Turco F; Turco F; Tucci M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Audisio A; Audisio M; Parlagreco E; Ungaro A; Scagliotti GV; Di Maio M; et alii...

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Di Stefano RF; Parlagreco E; Tucci M; Audisio M;

Prognostic significance of laterality in lung neuroendocrine tumors. in Endocrine / Endocrine. 2022 Jun;76(3):733-746. doi: 10.1007/s12020-022-03015-w. Epub 2022 Mar 18.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Ambrosio MR; Venuta F; Isidori A; Appetecchia M; Romero C; Volante M; Giannetta E; Panzuto F; Mancini M; Mazzilli R; Razzore P; Sesti F; Feola T; Baldelli R; Parlagreco E; Rinzivillo M; Puliani G; Trevisi E; Trabalza Marinucci B; Zanata I; Audisio A; Modica R; Bassi M; Verrico M; Siciliani A; Persano I; La Salvia A; Zatelli MC; Ibrahim M; et alii...

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond. in Cells / Cells. 2022 Jan 21;11(3):357. doi: 10.3390/cells11030357.

2022
ASL Asti
AOU San Luigi di Orbassano

Di Prima L; Di Stefano RF; Ungaro A; Audisio M; Parlagreco E; Delcuratolo MD; Buttigliero C; Audisio A; Turco F; Tucci M;

Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. in Seminars in oncology / Semin Oncol. 2022 Dec;49(6):476-481. doi: 10.1053/j.seminoncol.2023.01.007. Epub 2023 Feb 2.

2022
AOU San Luigi di Orbassano

Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP;

Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. in Medical oncology (Northwood, London, England) / Med Oncol. 2022 Aug 16;39(11):168. doi: 10.1007/s12032-022-01764-2.

2022
AOU San Luigi di Orbassano

La Salvia A; Persano I; Parlagreco E; Audisio A; Cani M; Brizzi MP;

Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.

2021
AOU San Luigi di Orbassano

Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;

Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review. in Comprehensive psychiatry / Compr Psychiatry. 2021 Aug;109:152244. doi: 10.1016/j.comppsych.2021.152244. Epub 2021 May 19.

2021
AOU San Luigi di Orbassano

La Salvia A; Portigliatti Pomeri A; Persano I; Trevisi E; Parlagreco E; Colombi N; Brizzi MP; Picci RL; Oliva F;

Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center. in Exploration of targeted anti-tumor therapy / Explor Target Antitumor Ther. 2021;2(5):481-489. doi: 10.37349/etat.2021.00058. Epub 2021 Oct 31.

2021
AOU San Luigi di Orbassano

Bungaro M; Bertaglia V; Audisio M; Parlagreco E; Pisano C; Cetoretta V; Persano I; Jacobs F; Baratelli C; Consito L; Reale ML; Tabbò F; Bironzo P; Scagliotti GV; Novello S;

Ocular metastases from neuroendocrine tumors: A literature review. in Seminars in oncology / Semin Oncol. 2020 Apr-Jun;47(2-3):144-147. doi: 10.1053/j.seminoncol.2020.04.003. Epub 2020 May 6.

2020
AOU San Luigi di Orbassano

La Salvia A; Persano I; Trevisi E; Parlagreco E; Muratori L; Scagliotti GV; Brizzi MP;